IVERIC bio, Inc.
ISEENASDAQHealthcare
$39.95
+$0.15(+0.38%)
Market Cap$5.5B
P/E Ratio—
52W High$39.99
52W Low$9.39
IVERIC bio, Inc. (ISEE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ISEE · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Jul 25, 2023EPS Actual
-$0.41
Est. -$0.49 · +16.3%
Revenue
—
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Jul 25, 2023
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
ISEE reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | May 8, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Feb 28, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 1, 2023 | — | — | — | — | — | — |
| ▲ Q3 FY2023 | Jul 25, 2023 | -$0.49 | -$0.41 | +16.3% | — | — | — |
| ▼ Q2 FY2023 | May 10, 2023 | -$0.44 | -$0.53 | -20.4% | — | — | — |
| ▼ Q1 FY2023 | Mar 1, 2023 | -$0.37 | -$0.47 | -27.0% | — | — | — |
| ▲ Q4 FY2022 | Nov 3, 2022 | -$0.40 | -$0.35 | +12.5% | — | — | — |
| ▼ Q3 FY2022 | Jul 26, 2022 | -$0.31 | -$0.41 | -32.3% | — | — | — |
Q2 FY2024
May 8, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 1, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Jul 25, 2023Beat
EPS Actual
-$0.41
EPS Est.
-$0.49
EPS Surpr.
+16.3%
Revenue
—
Q2 FY2023
May 10, 2023Miss
EPS Actual
-$0.53
EPS Est.
-$0.44
EPS Surpr.
-20.4%
Revenue
—
Q1 FY2023
Mar 1, 2023Miss
EPS Actual
-$0.47
EPS Est.
-$0.37
EPS Surpr.
-27.0%
Revenue
—
Q4 FY2022
Nov 3, 2022Beat
EPS Actual
-$0.35
EPS Est.
-$0.40
EPS Surpr.
+12.5%
Revenue
—
Q3 FY2022
Jul 26, 2022Miss
EPS Actual
-$0.41
EPS Est.
-$0.31
EPS Surpr.
-32.3%
Revenue
—
No analyst estimates available for ISEE.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2023 | Jul 25, 2023 | +16.3% | $39.95 | — | — |
| ▼ Q2 FY2023 | May 10, 2023 | -20.4% | $37.35 | $37.20 | -0.40% |
| ▼ Q1 FY2023 | Mar 1, 2023 | -27.0% | $20.78 | $24.30 | +16.94% |
| ▲ Q4 FY2022 | Nov 3, 2022 | +12.5% | $22.84 | $23.55 | +3.11% |
| ▼ Q3 FY2022 | Jul 26, 2022 | -32.3% | $10.77 | $11.04 | +2.51% |
| ▲ Q2 FY2022 | May 4, 2022 | +0.0% | $14.57 | $14.95 | +2.61% |
| ▼ Q1 FY2022 | Feb 24, 2022 | -20.8% | $14.16 | $15.20 | +7.34% |
| ▲ Q4 FY2021 | Nov 9, 2021 | +20.7% | $18.30 | $18.10 | -1.09% |
Q3 FY2023—
Report Date
Jul 25, 2023
EPS Beat/Miss
+16.3%
Price Before
$39.95
Price After
—
Q2 FY2023-0.40%
Report Date
May 10, 2023
EPS Beat/Miss
-20.4%
Price Before
$37.35
Price After
$37.20
Q1 FY2023+16.94%
Report Date
Mar 1, 2023
EPS Beat/Miss
-27.0%
Price Before
$20.78
Price After
$24.30
Q4 FY2022+3.11%
Report Date
Nov 3, 2022
EPS Beat/Miss
+12.5%
Price Before
$22.84
Price After
$23.55
Q3 FY2022+2.51%
Report Date
Jul 26, 2022
EPS Beat/Miss
-32.3%
Price Before
$10.77
Price After
$11.04
Q2 FY2022+2.61%
Report Date
May 4, 2022
EPS Beat/Miss
+0.0%
Price Before
$14.57
Price After
$14.95
Q1 FY2022+7.34%
Report Date
Feb 24, 2022
EPS Beat/Miss
-20.8%
Price Before
$14.16
Price After
$15.20
Q4 FY2021-1.09%
Report Date
Nov 9, 2021
EPS Beat/Miss
+20.7%
Price Before
$18.30
Price After
$18.10
Avg Beat Reaction+1.54%
Avg Miss Reaction+6.60%
Beat Rate4 / 8 quarters
Largest Move+16.94% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ISEE ends December
IVERIC bio, Inc. (ISEE) most recently reported earnings on July 25, 2023 for Q3 FY2023, posting EPS of $-0.41 — beating the analyst consensus of $-0.49 by +16.3%. The next ISEE earnings date is expected around September 1, 2026.
Each quarter, investors track ISEE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ISEE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ISEE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ISEE earnings · 5 questionsIVERIC bio, Inc.'s next earnings report is expected around September 1, 2026. ISEE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ISEE historically reports after market close (AMC).
ISEE earnings datewhen is ISEE earningsISEE next earnings datewhen does ISEE report earningsISEE earnings calendar
▸ Source: FMP · IVERIC bio, Inc. SEC filings · US GAAP · IVERIC bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026